[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

MultiCell Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MultiCell Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mycenax Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mycenax Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mylan, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mylan, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Mymetics Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Mymetics Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Myrexis, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myrexis, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Myriad Genetics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myriad Genetics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Myungmoon Pharmaceutical Co.,Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Myungmoon Pharmaceutical Co.,Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

MZT Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

MZT Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nabi Biopharmaceuticals Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nabi Biopharmaceuticals Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nang Kuang Pharmaceutical Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nang Kuang Pharmaceutical Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nano Dimensions, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nano Dimensions, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nanobac Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nanobac Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NanoCarrier Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoCarrier Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nanoco Group PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nanoco Group PLC Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NanoEntek, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoEntek, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NanoLogix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoLogix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nanoscience Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nanoscience Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nanosphere, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nanosphere, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NanoViricides, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoViricides, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nantong Jinghua Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nantong Jinghua Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NasVax Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NasVax Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Natco Pharma Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natco Pharma Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

National Pharmaceutical Industries Company SOAG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

National Pharmaceutical Industries Company SOAG Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

National Pharmaceuticals Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

National Pharmaceuticals Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Natraceutical SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natraceutical SA Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Natural Capsules Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Natural Capsules Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Naturewell Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Naturewell Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Navamedic Asa Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Navamedic Asa Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nectar Lifesciences Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nectar Lifesciences Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Nektar Therapeutics Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nektar Therapeutics Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neogenomics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neogenomics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NeoPharm, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeoPharm, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Caladrius Biosciences, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caladrius Biosciences, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neovacs S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neovacs S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuland Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuland Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuralstem Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuralstem Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuren Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuren Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuro Bioscience Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuro Bioscience Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuro-Hitech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuro-Hitech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurobiological Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurobiological Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurocrine Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurocrine Biosciences Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

OncoSil Medical Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoSil Medical Limited Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurogenesis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurogenesis Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NeurogesX, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeurogesX, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurokine Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurokine Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurologix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurologix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neuron BPh Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neuron BPh Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Neurosearch A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Neurosearch A/S Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

NeuroVive Pharmaceutical AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NeuroVive Pharmaceutical AB Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Newron Pharmaceuticals S.p.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Newron Pharmaceuticals S.p.A. Fundamental Company Report provides a complete overview of the company’s affairs.

September 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers